Emergent SARS-CoV-2 Variants
In silico analysis has shown that the FTD SARS-CoV-2 Assay detects the emergent SARS-CoV-2 variants, first identified in the UK and South Africa, at a rate of 100%.*
Respiratory Testing
For the specific detection of the coronavirus causing COVID-19
In late 2019, China notified the World Health Organization (WHO) of a novel strain of coronavirus. This virus, now named SARS-CoV-2, targets the epithelial cells of the respiratory tract and causes infection that can lead to Coronavirus disease 2019 (COVID-19). Siemens Healthineers new molecular assay uses real-time PCR to detect RNA from this virus.